Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-026409
Filing Date
2025-07-18
Accepted
2025-07-18 16:05:42
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3291
  Complete submission text file 0001140361-25-026409.txt   4817
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address
Dolsten Mikael (Reporting) CIK: 0001437590 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 251134558